Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20090089 | 0.88 | HPGD (0.35) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL20090112 | 0.85 | HPGD (0.34) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL20096624 | 0.84 | TUBB4A (0.32) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL20090133 | 0.83 | ALDH1A1 (0.32) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL20090222 | 0.81 | HPGD (0.39) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL20090084 | 0.81 | HPGD (0.34) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL20090106 | 0.80 | HPGD (0.34) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL20090120 | 0.77 | ALDH1A1 (0.32) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL20090076 | 0.77 | HPGD (0.38) | KDM4EALDH1A1HPGDLMNATP53 | |
| SCHEMBL19960322 | 0.75 | CYP11B1 (0.32) | KDM4EALDH1A1HPGDLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180114923-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180114923-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | KDM4E 1997/4885ALDH1A1 750/4885HPGD 2982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.